Cancer Research in Switzerland - Krebsliga Schweiz
Cancer Research in Switzerland - Krebsliga Schweiz
Cancer Research in Switzerland - Krebsliga Schweiz
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
De Libero Gennaro | KLS 02211-02-2008 | CHF 159,500.–<br />
Experimentelle Immunologie, Departement Biomediz<strong>in</strong>, Universität Basel, Basel<br />
Lipid-specific T-cells aga<strong>in</strong>st leukaemic blasts<br />
Dirnhofer Stephan | OCS 01792-10-2005 | CHF 297,800.–<br />
Institut für Pathologie, Universitätsspital Basel, Basel<br />
Induc<strong>in</strong>g cell death <strong>in</strong> apoptosis-resistant hematological tumors: Impact on diagnosis and therapeutic<br />
<strong>in</strong>tervention<br />
Doucey Marie-Agnès | OCS 02069-04-2007 | CHF 214,800.–<br />
Centre pluridiscipl<strong>in</strong>aire d’oncologie (CePO), Centre hospitalier universitaire vaudois (CHUV), Lausanne<br />
Functional and biochemical characterization of human monocyte-like circulat<strong>in</strong>g cells <strong>in</strong> breast cancer patients:<br />
Relevance to tumor growth and angiogenesis<br />
Dubey Raghvendra K. | OCS 01551-08-2004 | CHF 258,300.–<br />
Kl<strong>in</strong>ik für Reproduktions-Endokr<strong>in</strong>ologie, UniversitätsSpital Zürich, Zürich<br />
Pathophysiological role of estrogen metabolism <strong>in</strong> breast cancer<br />
Fratt<strong>in</strong>i Milo | OCS 01921-08-2006 | CHF 102,300.–<br />
Laboratorio di diagnostica molecolare, Istituto cantonale di patologia (ICP), Locarno<br />
Characterization of EGFR deregulation and EGFR downstream cascade <strong>in</strong> colorectal cancer patients, and<br />
relationship to new targeted therapies<br />
Garayoa Elisa Garcia | KLS 02040-02-2007 | CHF 150,700.–<br />
Zentrum für radiopharmazeutische Wissenschaften, Paul Scherrer Institut (PSI), Villigen<br />
Development of new bombes<strong>in</strong>-based radiopharmaceuticals with improved pharmacok<strong>in</strong>etics as potential<br />
imag<strong>in</strong>g and therapeutic agents for bombes<strong>in</strong> receptor-positive tumours<br />
Gautschi Oliver | KLS 02164-02-2008 | CHF 218,200.–<br />
Departement für kl<strong>in</strong>ische Forschung, Universität Bern, Inselspital, Bern<br />
Regulation of lD1 expression by Src <strong>in</strong> cancer: Cl<strong>in</strong>ical implications<br />
Heim Markus Hermann | OCS 02192-02-2008 | CHF 245,200.–<br />
Kl<strong>in</strong>ik für Gastroenterologie und Hepatologie, Universitätsspital Basel, Basel<br />
Hepatocarc<strong>in</strong>ogenesis <strong>in</strong> chronic hepatitis C<br />
Cont<strong>in</strong>uation of the project:<br />
Heim Markus Hermann | KLS 01832-02-2006 | CHF 231,700.–<br />
Kl<strong>in</strong>ik für Gastroenterologie und Hepatologie, Universitätsspital Basel, Basel<br />
Hepatocarc<strong>in</strong>ogenesis <strong>in</strong> chronic hepatitis C<br />
He<strong>in</strong>zelmann-Schwarz Viola | OCS 02115-08-2007 | CHF 232,100.–<br />
Translational <strong>Research</strong> Group, Kl<strong>in</strong>ik für Gynäkologie, Mediz<strong>in</strong>bereich Frau-K<strong>in</strong>d, UniversitätsSpital Zürich<br />
Detection of anti-glycan autoantibodies as biomarkers of high stage serous ovarian cancer; acronym:<br />
GOS-study<br />
Herrmann Richard | KLS 02067-04-2007 | CHF 490,000.–<br />
<strong>Schweiz</strong>erische Arbeitsgeme<strong>in</strong>schaft für Kl<strong>in</strong>ische Krebsforschung (SAKK), Koord<strong>in</strong>ationszentrum, Bern<br />
The SAKK <strong>in</strong>itiative for regional hospitals<br />
Hess Christoph | OCS 02266-08-2008 | CHF 103,700.–<br />
Ambulante Innere Mediz<strong>in</strong>, Mediz<strong>in</strong>ische Polikl<strong>in</strong>ik, Universitätsspital Basel, Basel<br />
Innate immunity, cytok<strong>in</strong>e polymorphisms, and development of post-transplant lymphoproliferative disease<br />
<strong>in</strong> kidney transplant recipients<br />
Hess Viviane | KLS 01881-04-2006 | CHF 87,800.–<br />
Mediz<strong>in</strong>ische Onkologie, Universitätsspital Basel, Basel<br />
Improv<strong>in</strong>g treatment for patients with advanced pancreatic cancer (APC): A Swiss-wide effort<br />
Hoek Keith | OCS 01927-08-2006 | CHF 145,500.–<br />
Dermatologische Kl<strong>in</strong>ik, Mediz<strong>in</strong>bereich Trauma-Derma-Rheuma-Plastische Chirurgie, UniversitätsSpital Zürich,<br />
Zürich<br />
Cl<strong>in</strong>ical implications of Wnt signal-driven regulation of melanoma metastatic potential<br />
121